CA20317-1 - 0x00000000000030BE

Study Number: CA20317
Group Number: 1
Study Requirement: Healthy Male and Female
Stipend: $3,500.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 18.5 - 32
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to balance electroytes in patients with kidney disease.
  • Route of Administration: Oral
  • Blood Draws: 60

Study Schedule:

  • Schedule Type: Week End
  • Study Length: 3 - Three Night Stays & 1 Phone Call

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Tuesday 9/26/2017

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Tuesday 9/26/2017

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Friday 9/29/2017 1:00:00 PM Monday 10/2/2017 8:00:00 AM 1 Lincoln
Check-In Friday 10/13/2017 1:00:00 PM Monday 10/16/2017 8:00:00 AM 2 Lincoln
Check-In Friday 10/20/2017 1:00:00 PM Monday 10/23/2017 8:00:00 AM 3 Lincoln
Phone participant* Sunday 11/5/2017 6:00:00 AM 3 Lincoln